Jan Hartmann, M.D.

Jan Hartmann, M.D.

janhartmannmd.bsky.social

Bringing Med to MedTech - Physician, Scientist, Photographer, Traveler, Berliner, Immigrant 🇩🇪🇺🇸 - Views=My own, Like/RT≠Endorsement; Haemonetics employee

👤 Joined on 11 November 2024

174

Followers

54

Following

87

Total Posts

📜 Kullanıcı Geçmişi

  • 11 Kas 2024, 14:58
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @janhartmannmd.bsky.social

❤️ Beğendiği Gönderiler

The Lancet
02 October 2026 14:19

Peripheral arterial disease (PAD) affects more than 300 million people worldwide—yet it remains under-recognised, underdiagnosed, and undertreated. A new Editorial discusses a Lancet Series aiming to address this major health burden: spkl.io/633207pL2I

Show Post
The Lancet
22 September 2026 22:34

Peripheral arterial disease (PAD) affects more than 300 million people worldwide—yet it remains under-recognised, underdiagnosed, and undertreated. A new Series aims to address this major health burden: spkl.io/633217rwP1

Show Post

An expert panel established consensus clinical criteria to adjudicate the presence of actionable hemorrhage in chart review of injured children https://www.ovid.com/jnls/jtrauma/abstract/10.1097/ta.0000000000004958~consensus-based-criteria-for-actionable-hemorrhage-in?redirectionsource=fulltextview

Show Post

“The discovery of orexins & their link to narcolepsy became central for understanding sleep–wake regulation itself.” 🧪Sebastiaan Overeem & Birgitte R. Kornum report in @nejm.org on the pivotal roles that #LaskerAward winners Mignot & Yanagisawa had in the discovery of orexin: buff.ly/T3CPftu

Show Post
NEJM.org
30 August 2026 09:23

In patients with severe aortic stenosis and coronary artery disease, a strategy of transcatheter aortic-valve implantation before percutaneous coronary intervention was noninferior to PCI before TAVI for major clinical events at 1 year. Full TAVI PCI results: https://nej.md/3SlY3SF #ESCCongress

Show Post

Select language

Install App

Install App